Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Clinical Application of Lunit AI For Chest Radiography and Mammography to Be Presented at AOCR 2021
2021-06-23 10:28
Sintilimab in Combination with Chemotherapy Meets Overall Survival Primary Endpoint in the Global Phase 3 ORIENT-15 Study for the First-Line Treatment of Esophageal Squamous Cell Carcinoma
2021-06-23 09:16
Global Water Scarcity and Hospitalization Rates Stimulate the Polymeric Membranes Market
2021-06-23 00:14
Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform
2021-06-22 20:28
Alfasigma acquires the European license for bentracimab from PhaseBio
2021-06-22 14:45
Asieris Announces First Patient Treated in Europe in APRICITY, the Multinational Phase III Clinical Trial of APL-1702, Cevira®
2021-06-22 13:15
2021 ASCO - AnchorDx Unveils Robust Validation Result of Multi-cancer Screening Technology AURORA
2021-06-21 23:19
I-Mab Appoints International Gastrointestinal Oncology Expert Dr. Andrew Zhu to its Scientific Advisory Board
2021-06-21 20:00
RedHill Biopharma Announces Presentation of Positive Oral Opaganib Phase 2 Data in COVID-19
2021-06-21 19:00
HUTCHMED Announces NMPA Approval of Surufatinib (Sulanda(R) in China) for Advanced Pancreatic Neuroendocrine Tumors
2021-06-21 15:15
CStone announces first prescriptions of precision therapy GAVRETO® (pralsetinib) issued across China for the treatment of adults with locally advanced or metastatic RET fusion-positive non-small cell lung cancer after platinum-based chemotherapy
2021-06-21 13:06
Study Results of Sintilimab in Combination with Bevacizumab Biosimilar IBI305 for the First-Line Treatment of Hepatocellular Carcinoma Published in The Lancet Oncology
2021-06-21 08:00
CARsgen Therapeutics officially listing on HKEX
2021-06-19 02:57
Latest testing confirms Viraleze highly effective against Alpha, Beta and Gamma COVID variants
2021-06-18 14:16
Latest testing confirms Viraleze highly effective against Alpha, Beta and Gamma COVID variants
2021-06-18 14:04
Gilead Sciences Announces Subanalyses of Safety and Efficacy Data from a Phase 2 Study of Chronic Hepatitis B Patients with Renal or Hepatic Impairment Switching to Vemlidy(r)
2021-06-18 10:00
Jacobio Announces First Two Patients Dosed in SHP2 Combination Study, Triggering US$20 Million Milestone Payment
2021-06-18 08:31
Innovent Announces First Patient Dosed in the Phase II Basket Trial of Taletrectinib for Solid Tumors with NTRK Fusion
2021-06-18 08:00
Envirotainer Announces Cathay Pacific as First Asian carrier for the recently released Releye® RLP container
2021-06-17 19:49
Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients
2021-06-17 14:38
1
238
239
240
241
242
413